0.71
-0.1399(-16.46%)
Currency In USD
Address
1140 Avenue of the America
New York City, NY 10036
United States of America
Phone
781 652 4500
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2
First IPO Date
June 27, 2017
| Name | Title | Pay | Year Born |
| Dr. Alexandra MacLean M.D. | Chief Executive Officer & Director | 433,800 | 1968 |
| Dr. Scott A. Reines M.D., Ph.D. | Interim Chief Medical Officer | 69,120 | 1947 |
| Dr. Lindsay Allan Rosenwald | Executive Director | 0 | 1955 |
| Mr. David Jin | Interim Chief Financial Officer, Chief Operating Officer & Corporate Secretary | 0 | 1991 |
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
